Sesslar MedSpa

Med Spa • Newport, KY

About

Book appointment Call clinic Visit website

Sesslar MedSpa is a medical spa in Newport, KY offering Botox, dermal fillers including Juvederm and Restylane, and skin rejuvenation treatments. Led by Dr. Christopher Sesslar, M.D., the practice provides customized aesthetic services designed to address fine lines, skin texture, and signs of aging while maintaining a natural appearance.

Clinic Type

Med Spa

Address

530 W. 9th St., Suite 201, Newport, KY 41071

Phone

(937) 903-5731

Email

—

Opening Hours

Not published — contact the clinic to confirm hours.

Website

https://www.sesslarmedspa.com/

Services Offered

Botox
Dermal Fillers
Skin Rejuvenation
Cosmetic Laser
IPL
Laser Resurfacing
Thulityte-
Juvéderm
Skin Rejuvenation (general)
Cosmetic Laser (general)
Master Aesthetic Artist™ Services

Technology & Equipment

Botox
Dermal Fillers (Juvederm)
IPL (Intense Pulsed Light)
Laser Resurfacing
Thulityte-

Team

Dr. Christopher Sesslar, M.D. — M.D., Newport, KY MedSpa Doctor

Insurance & Payment

—

Languages Spoken

—

Social Media

Facebook Instagram

Photos

What Patients Say

Overall sentiment across review platforms: positive

Healthgrades (Dr. Christopher Sesslar): 4.3/5 (24 reviews)
TrustAnalytica (Spa Medicca): 5.0/5 (103 reviews)

Patients praise

Highly skilled and knowledgeable physician
Professional and friendly staff
Effective Botox and cosmetic results
Stress-free and comfortable environment
Informative patient care and follow-ups

Common complaints

Some negative sentiment identified in physician-specific reviews regarding Dr. Sesslar, although unrelated to a specific Newport location complaint history.

"Dr. Sesslar is an excellent Physician and treats his patients with the utmost care and professionalism."

— Healthgrades (Dr. Christopher Sesslar)

"Dr. SESSLAR IS AN AMAZING PHYSICIAN AND HIS STAFF IS ALSO AMAZING. THEY TAKE THE TIME TO ANSWER YOUR QUESTIONS AND GIVE YOU THE BEST EXPERIENCE."

— Healthgrades (Dr. Christopher Sesslar)

Synthesized from public review platforms as of Jul 11, 2026 — sources: [1][2][3][4].